Skip to main content
Top
Gepubliceerd in: Cognitive Therapy and Research 1/2010

01-02-2010 | Original Article

The Role of Cognitive-Behavioral Therapy and Fluoxetine in Prevention of Recurrence of Major Depressive Disorder

Auteurs: Timothy J. Petersen, Joel A. Pava, Jacqueline Buchin, John D. Matthews, George I. Papakostas, Andrew A. Nierenberg, Avram J. Holmes, Ryan Bogdan, Lesley M. Graves, Rebecca M. Harley, Maurizio Fava

Gepubliceerd in: Cognitive Therapy and Research | Uitgave 1/2010

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

This study evaluated the role of cognitive-behavioral therapy (CBT) and fluoxetine in preventing recurrence of a depressive episode during maintenance phase treatment for patients with remitted major depressive disorder (MDD). Patients (n = 52) completed open acute fluoxetine treatment and sustained remission during a 28-week randomized continuation treatment (CBT + fluoxetine vs. fluoxetine only). They were assigned to one of four maintenance treatments: CBT + fluoxetine, CBT + placebo, fluoxetine only, and placebo only. There were no statistically significant differences in MDD recurrence between maintenance treatments, but continued antidepressant treatment (with or without CBT) provided an 18–21% lower MDD recurrence rate than placebo. These findings are consistent with those of recent antidepressant studies of chronic and recurrent MDD populations. Although sample sizes were small, CBT did not significantly lower rates of MDD recurrence.
Literatuur
go back to reference Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988). An inventory for measuring clinical anxiety: Psychometric properties. Journal of Consulting and Clinical Psychology, 56, 893–897.CrossRefPubMed Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988). An inventory for measuring clinical anxiety: Psychometric properties. Journal of Consulting and Clinical Psychology, 56, 893–897.CrossRefPubMed
go back to reference Beck, A. T., Rush, A. J., Shaw, B. F., & Emery, G. (1979). Cognitive therapy of depression. New York: Guilford Press. Beck, A. T., Rush, A. J., Shaw, B. F., & Emery, G. (1979). Cognitive therapy of depression. New York: Guilford Press.
go back to reference Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 561–571.PubMed Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 561–571.PubMed
go back to reference Beck, A. T., Weissman, A., Lester, D., & Trexler, L. (1974). The measurement of pessimism: The hopelessness scale. Journal of Consulting and Clinical Psychology, 42, 861–865.CrossRefPubMed Beck, A. T., Weissman, A., Lester, D., & Trexler, L. (1974). The measurement of pessimism: The hopelessness scale. Journal of Consulting and Clinical Psychology, 42, 861–865.CrossRefPubMed
go back to reference Blackburn, I. M., Eunson, K. M., & Bishop, S. (1986). A two-year naturalistic follow-up of depressed patients treated with cognitive therapy, pharmacotherapy, and a combination of both. Journal of Affective Disorders, 10, 67–75.CrossRefPubMed Blackburn, I. M., Eunson, K. M., & Bishop, S. (1986). A two-year naturalistic follow-up of depressed patients treated with cognitive therapy, pharmacotherapy, and a combination of both. Journal of Affective Disorders, 10, 67–75.CrossRefPubMed
go back to reference Blackburn, I. M., & Moore, R. G. (1997). Controlled acute and follow-up trial of cognitive therapy and pharmacotherapy in out-patients with recurrent depression. British Journal of Psychiatry, 171, 328–334.CrossRefPubMed Blackburn, I. M., & Moore, R. G. (1997). Controlled acute and follow-up trial of cognitive therapy and pharmacotherapy in out-patients with recurrent depression. British Journal of Psychiatry, 171, 328–334.CrossRefPubMed
go back to reference Fava, G. A. (1999). Subclinical symptoms in mood disorders: Pathophysiological and therapeutic implications. Psychological Medicine, 29, 47–61.CrossRefPubMed Fava, G. A. (1999). Subclinical symptoms in mood disorders: Pathophysiological and therapeutic implications. Psychological Medicine, 29, 47–61.CrossRefPubMed
go back to reference Fava, M., Alpert, J., Nierenberg, A., Lagomasino, I., Sonawalla, S., Tedlow, J., et al. (2002). Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine. Journal of Clinical Psychopharmacology, 22, 379–387.CrossRefPubMed Fava, M., Alpert, J., Nierenberg, A., Lagomasino, I., Sonawalla, S., Tedlow, J., et al. (2002). Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine. Journal of Clinical Psychopharmacology, 22, 379–387.CrossRefPubMed
go back to reference Fava, M., & Kaji, J. (1994). Continuation and maintenance treatments of major depressive disorder. Psychiatric Annuals, 42, 281–290. Fava, M., & Kaji, J. (1994). Continuation and maintenance treatments of major depressive disorder. Psychiatric Annuals, 42, 281–290.
go back to reference Fava, G. A., Rafanelli, C., Cazzaro, M., Conti, S., & Grandi, S. (1998a). Well-being therapy: A novel psychotherapeutic approach for residual symptoms of affective disorders. Psychological Medicine, 28, 475–480.CrossRefPubMed Fava, G. A., Rafanelli, C., Cazzaro, M., Conti, S., & Grandi, S. (1998a). Well-being therapy: A novel psychotherapeutic approach for residual symptoms of affective disorders. Psychological Medicine, 28, 475–480.CrossRefPubMed
go back to reference Fava, G. A., Rafanelli, C., Grandi, S., Canestrari, R., & Morphy, M. A. (1998b). Six-year outcome for cognitive behavioral treatment of residual symptoms in major depression. American Journal of Psychiatry, 155, 1443–1445.PubMed Fava, G. A., Rafanelli, C., Grandi, S., Canestrari, R., & Morphy, M. A. (1998b). Six-year outcome for cognitive behavioral treatment of residual symptoms in major depression. American Journal of Psychiatry, 155, 1443–1445.PubMed
go back to reference Fava, G. A., Rafanelli, C., Grandi, S., Conti, S., & Belluardo, P. (1998c). Prevention of recurrent depression with cognitive behavioral therapy: Preliminary findings. Archives of General Psychiatry, 55, 816–820.CrossRefPubMed Fava, G. A., Rafanelli, C., Grandi, S., Conti, S., & Belluardo, P. (1998c). Prevention of recurrent depression with cognitive behavioral therapy: Preliminary findings. Archives of General Psychiatry, 55, 816–820.CrossRefPubMed
go back to reference Fawcett, J., Epstein, P., Fiester, S. J., Elkin, I., & Autry, J. H. (1987). Clinical management: Imipramine/placebo administration manual. Psychopharmacology Bulletin, 23, 309–323.PubMed Fawcett, J., Epstein, P., Fiester, S. J., Elkin, I., & Autry, J. H. (1987). Clinical management: Imipramine/placebo administration manual. Psychopharmacology Bulletin, 23, 309–323.PubMed
go back to reference Frank, E., Kupfer, D. J., Perel, J. M., Cornes, C., Jarrett, D. B., Mallinger, A. G., et al. (1990). Three-year outcomes for maintenance therapies in recurrent depression. Archives of General Psychiatry, 47, 1093–1099.PubMed Frank, E., Kupfer, D. J., Perel, J. M., Cornes, C., Jarrett, D. B., Mallinger, A. G., et al. (1990). Three-year outcomes for maintenance therapies in recurrent depression. Archives of General Psychiatry, 47, 1093–1099.PubMed
go back to reference Gelenberg, A. J., Trivedi, M. H., Rush, A. J., Thase, M. E., Howland, R., Klein, D. N., et al. (2003). Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression. Biological Psychiatry, 54, 806–817.CrossRefPubMed Gelenberg, A. J., Trivedi, M. H., Rush, A. J., Thase, M. E., Howland, R., Klein, D. N., et al. (2003). Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression. Biological Psychiatry, 54, 806–817.CrossRefPubMed
go back to reference Guy, W. (Ed.) (1976). ECDEU assessment manual for psychopharmacology, revised [DHEW Pub. No. (ADM) 76-338]. Rockville, MD: National Institute of Mental Health. Guy, W. (Ed.) (1976). ECDEU assessment manual for psychopharmacology, revised [DHEW Pub. No. (ADM) 76-338]. Rockville, MD: National Institute of Mental Health.
go back to reference Hamilton, M. (1960). A rating scale for depression. Journal of Neurology and Neurosurgery Psychiatry, 23, 56–62.CrossRef Hamilton, M. (1960). A rating scale for depression. Journal of Neurology and Neurosurgery Psychiatry, 23, 56–62.CrossRef
go back to reference Jarrett, R. B., Kraft, D., Doyle, J., Foster, B. M., Eaves, G. G., & Silver, P. C. (2001). Preventing recurrent depression using cognitive therapy with and without a continuation phase. Archives of General Psychiatry, 58, 381–388.CrossRefPubMed Jarrett, R. B., Kraft, D., Doyle, J., Foster, B. M., Eaves, G. G., & Silver, P. C. (2001). Preventing recurrent depression using cognitive therapy with and without a continuation phase. Archives of General Psychiatry, 58, 381–388.CrossRefPubMed
go back to reference Judd, L. L., Akiskal, H. S., & Paulus, M. P. (1997). The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar major depressive disorder. Journal of Affective Disorders, 45(1–2), 5–18.CrossRefPubMed Judd, L. L., Akiskal, H. S., & Paulus, M. P. (1997). The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar major depressive disorder. Journal of Affective Disorders, 45(1–2), 5–18.CrossRefPubMed
go back to reference Keller, M. B., Kocsis, J. H., Thase, M. E., Gelenberg, A. J., Rush, A. J., Koran, L., et al. (1998). Maintenance phase efficacy of sertraline for chronic depression: A randomized controlled trial. Journal of the American Medical Association, 280, 1665–1672.CrossRefPubMed Keller, M. B., Kocsis, J. H., Thase, M. E., Gelenberg, A. J., Rush, A. J., Koran, L., et al. (1998). Maintenance phase efficacy of sertraline for chronic depression: A randomized controlled trial. Journal of the American Medical Association, 280, 1665–1672.CrossRefPubMed
go back to reference Kellner, R. (1987). A symptom questionnaire. Journal of Clinical Psychiatry, 48, 268–274.PubMed Kellner, R. (1987). A symptom questionnaire. Journal of Clinical Psychiatry, 48, 268–274.PubMed
go back to reference Klein, D. N., Santiago, N. J., Vivian, D., Blalock, J. A., Kocsis, J. H., Markowitz, J. C., et al. (2004). Cognitive-behavioral analysis system of psychotherapy as a maintenance treatment for chronic depression. Journal of Consulting and Clinical Psychology, 72, 681–688.CrossRefPubMed Klein, D. N., Santiago, N. J., Vivian, D., Blalock, J. A., Kocsis, J. H., Markowitz, J. C., et al. (2004). Cognitive-behavioral analysis system of psychotherapy as a maintenance treatment for chronic depression. Journal of Consulting and Clinical Psychology, 72, 681–688.CrossRefPubMed
go back to reference McCullough, J. P. Jr., Klein, D. N., Borian, F. E., et al. (2003). Group comparisons of DSM-IV subtypes of chronic depression: Validity of the distinctions, part 2. Journal of Abnormal Psychology, 112, 614–622.CrossRefPubMed McCullough, J. P. Jr., Klein, D. N., Borian, F. E., et al. (2003). Group comparisons of DSM-IV subtypes of chronic depression: Validity of the distinctions, part 2. Journal of Abnormal Psychology, 112, 614–622.CrossRefPubMed
go back to reference Mercier, M. A., & Leahy, R. L. (1992). Cognitive therapy of dysthymia: A treatment manual. Unpublished manuscript, Columbia-Presbyterian Hospital, New York. Mercier, M. A., & Leahy, R. L. (1992). Cognitive therapy of dysthymia: A treatment manual. Unpublished manuscript, Columbia-Presbyterian Hospital, New York.
go back to reference Pava, J. A., Fava, M., & Levenson, J. A. (1994). Integrating cognitive therapy and pharmacotherapy in the treatment and prophylaxis of depression: A novel approach. Psychotherapy and Psychosomatics, 61, 211–219.PubMedCrossRef Pava, J. A., Fava, M., & Levenson, J. A. (1994). Integrating cognitive therapy and pharmacotherapy in the treatment and prophylaxis of depression: A novel approach. Psychotherapy and Psychosomatics, 61, 211–219.PubMedCrossRef
go back to reference Pava, J. A., McDermott, S. P., & Fava, M. (1996). Cognitive therapy of remitted depressives at high risk for relapse/recurrence: A treatment manual. Unpublished manuscript. Pava, J. A., McDermott, S. P., & Fava, M. (1996). Cognitive therapy of remitted depressives at high risk for relapse/recurrence: A treatment manual. Unpublished manuscript.
go back to reference Paykel, E. S., Scott, J., Teasdale, J. D., Johnson, A. L., Garlan, A., Moore, R., et al. (1999). Prevention of relapse in residual depression by cognitive therapy. Archives of General Psychiatry, 56, 829–835.CrossRefPubMed Paykel, E. S., Scott, J., Teasdale, J. D., Johnson, A. L., Garlan, A., Moore, R., et al. (1999). Prevention of relapse in residual depression by cognitive therapy. Archives of General Psychiatry, 56, 829–835.CrossRefPubMed
go back to reference Perlis, R. H., Nierenberg, A. A., Alpert, J. E., Pava, J., Matthews, J. D., Buchin, J., et al. (2002). Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder. Journal of Clinical Psychopharmacology, 22, 474–480.CrossRefPubMed Perlis, R. H., Nierenberg, A. A., Alpert, J. E., Pava, J., Matthews, J. D., Buchin, J., et al. (2002). Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder. Journal of Clinical Psychopharmacology, 22, 474–480.CrossRefPubMed
go back to reference Reimherr, F. W., Amsterdam, J. D., Quitkin, F. M., Rosenbaum, J. F., Fava, M., Zajecka, J., et al. (1998). Optimal length of continuation therapy in depression: A prospective assessment during long-term fluoxetine treatment. American Journal of Psychiatry, 155, 1247–1253.PubMed Reimherr, F. W., Amsterdam, J. D., Quitkin, F. M., Rosenbaum, J. F., Fava, M., Zajecka, J., et al. (1998). Optimal length of continuation therapy in depression: A prospective assessment during long-term fluoxetine treatment. American Journal of Psychiatry, 155, 1247–1253.PubMed
go back to reference Reynolds, C. F. III, Frank, E., Perel, J. M., Imber, S. D., Cornes, C., Miller, M. D., et al. (1999) Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: A randomized controlled trial in patients older than 59 years. Journal of the American Medical Association, 281, 39–45.CrossRefPubMed Reynolds, C. F. III, Frank, E., Perel, J. M., Imber, S. D., Cornes, C., Miller, M. D., et al. (1999) Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: A randomized controlled trial in patients older than 59 years. Journal of the American Medical Association, 281, 39–45.CrossRefPubMed
go back to reference Segal, Z., Vincent, P., & Levitt, A. (2002). Efficacy of combined, sequential and crossover psychotherapy and pharmacotherapy in improving outcomes in depression. Journal of Psychiatry and Neuroscience, 27, 281–290.PubMed Segal, Z., Vincent, P., & Levitt, A. (2002). Efficacy of combined, sequential and crossover psychotherapy and pharmacotherapy in improving outcomes in depression. Journal of Psychiatry and Neuroscience, 27, 281–290.PubMed
go back to reference Shea, M. T., Elkin, I., Imber, S. D., Sotsky, S. M., Watkins, J. T., Collins, J. F., et al. (1992). Course of depressive symptoms over follow-up. Findings from the National Institute of Mental Health Treatment of Depression Collaborative Research Program. Archives of General Psychiatry, 49, 782–787.PubMed Shea, M. T., Elkin, I., Imber, S. D., Sotsky, S. M., Watkins, J. T., Collins, J. F., et al. (1992). Course of depressive symptoms over follow-up. Findings from the National Institute of Mental Health Treatment of Depression Collaborative Research Program. Archives of General Psychiatry, 49, 782–787.PubMed
go back to reference Spitzer, R. L., Williams, J. B. W., Gibbon, M., & First, M. B. (1989). Structured clinical interview for DSM-III-R—Patient Edition (SCID-P, 9/1/89 Version). New York: Biometrics Research. Spitzer, R. L., Williams, J. B. W., Gibbon, M., & First, M. B. (1989). Structured clinical interview for DSM-III-R—Patient Edition (SCID-P, 9/1/89 Version). New York: Biometrics Research.
go back to reference Teasdale, J. D., Segal, Z. V., Williams, J. M., Ridgeway, V. A., Soulsby, J. M., & Lau, M. A. (2000). Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Journal of Consulting and Clinical Psychology, 68, 615–623.CrossRefPubMed Teasdale, J. D., Segal, Z. V., Williams, J. M., Ridgeway, V. A., Soulsby, J. M., & Lau, M. A. (2000). Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Journal of Consulting and Clinical Psychology, 68, 615–623.CrossRefPubMed
Metagegevens
Titel
The Role of Cognitive-Behavioral Therapy and Fluoxetine in Prevention of Recurrence of Major Depressive Disorder
Auteurs
Timothy J. Petersen
Joel A. Pava
Jacqueline Buchin
John D. Matthews
George I. Papakostas
Andrew A. Nierenberg
Avram J. Holmes
Ryan Bogdan
Lesley M. Graves
Rebecca M. Harley
Maurizio Fava
Publicatiedatum
01-02-2010
Uitgeverij
Springer US
Gepubliceerd in
Cognitive Therapy and Research / Uitgave 1/2010
Print ISSN: 0147-5916
Elektronisch ISSN: 1573-2819
DOI
https://doi.org/10.1007/s10608-007-9166-6

Andere artikelen Uitgave 1/2010

Cognitive Therapy and Research 1/2010 Naar de uitgave